Recent Reports


In collaboration with researchers at the Office of Health Economics (OHE), ICER has published a new white paper: “Cornerstones of ‘Fair’ Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals.” The purpose of the white paper is to analyze the ethical and practical dimensions of insurance coverage policy, while presenting a corresponding set of criteria that will support a more transparent discussion among all health care stakeholders about whether specific cost sharing and utilization management policies are delivering “fair” patient access to prescription drugs.





Materials

ICER

Cornerstones of “Fair” Drug Coverage

CTAF

Alzheimer’s Disease, 2021: Stakeholder List

CTAF

Alzheimer’s Disease, 2021: Draft Scoping Document

CTAF

Alzheimer’s Disease, 2021: Open Input

Integrated product development for ATMPs

ICER

PTSD Service Dogs: Open Input

Midwest CEPAC

Multiple Myeloma Update: Research Protocol

Midwest CEPAC

Multiple Myeloma Update: Revised Scoping Document

Midwest CEPAC

Multiple Myeloma Update: Stakeholder List

Midwest CEPAC

Multiple Myeloma Update: Public Comments on Draft Scoping Document

Midwest CEPAC

Multiple Myeloma Update: Draft Scoping Document

Midwest CEPAC

Multiple Myeloma Update: Open Input